28/09/2026
As we prepare for this Fall’s Programa Desafía Boston, an initiative by ICEX powered by Richi LifeSciences, we are proud to spotlight another incredible member of our alumni community: PlusVitech. Soluciones Oncológicas.
PlusVitech is a Spanish biotechnology company developing safe, targeted therapeutic treatments for cancer, driven by a vital mission to restore hope to patients who have exhausted traditional options.
Having joined us during our inaugural Desafía Boston edition, their team experienced firsthand what true immersion in the world's leading life sciences hub can unlock.
"To PlusVitech, Desafía Boston was a true gateway to the global ecosystem," shares Fran Guillén, CBO at PlusVitech. "It allowed us to engage directly with top industry experts and establish high-value relationships that continue to open doors for our international expansion."
Stories like PlusVitech’s are a great reminder of why this program exists. Seeing Spanish founders take their science to Boston, make lasting global connections, and keep building that momentum long after the immersion ends is what it’s all about.
We can't wait to see where Fran and the PlusVitech team take their technology next!